PureTech
PureTech develops radical technology solutions for health.
Business Model:
Revenue: $11.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed PureTech Information
Geographic Data
Address: 500 Boylston St
City: Boston
State: MA
Zip: 02116
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$50M
Social
Metrics
3,594,613Website Global Rank
3,752Website Monthly Traffic
Twitter Followers
Description
PureTech develops radical technology solutions for health.
Contact Phone:
+16174822333
Contact Email:
PureTech went public on 6/26/2015 on the London Stock Exchange
Listed Exchange:
London Stock Exchange
IPO Date:
6/26/2015
Ticker Symbol:
PRTC
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2019 | Karuna Therapeutics | Series B | 0 |
| 4/2015 | Tal Medical | Series B | 14M |
| 1/2008 | Follica | Series A | 5.5M |
| 1/2017 | resTORbio | Series A | 25M |
| 1/2016 | Akili Interactive Labs | Series B | 0 |
| 1/2009 | Satori Pharmaceuticals | Series A | 22M |
| 1/2011 | Satori Pharmaceuticals | Series B | 7M |
| 6/2016 | Vedanta Biosciences | Private Equity Round | 0 |
| 6/2010 | Follica | Series B | 7.5M |
| 12/2006 | Gelesis | Series A | 500k |
| 4/2023 | Vedanta Biosciences | Series E | 0 |
| 11/2005 | Mersana Therapeutics | Venture Round | 21M |
| 12/2015 | Gelesis | Private Equity Round | 0 |
| 1/2008 | Gelesis | Series B | 16M |
| 12/2022 | Sonde Health | Series B | 19.3M |
| 11/2010 | Follica | Series B | 135k |
| 1/2005 | Satori Pharmaceuticals | Venture Round | 3M |
| 5/2007 | Solace Pharmaceuticals | Series A | 15M |
| 8/2008 | Follica | Series B | 11M |
| 7/2020 | Vor Biopharma | Series B | 0 |
| 8/2018 | Karuna Therapeutics | Series A | 0 |
| 7/2021 | Vedanta Biosciences | Series D | 0 |
| 5/2014 | Gelesis | Series E | 12M |
| 12/2018 | Vedanta Biosciences | Series C | 0 |
| 7/2021 | Vedanta Biosciences | Series D | 0 |
| 7/2020 | Vor Biopharma | Series B | 0 |
| 3/2019 | Karuna Therapeutics | Series B | 0 |
| 12/2018 | Vedanta Biosciences | Series C | 0 |
| 8/2018 | Karuna Therapeutics | Series A | 0 |
| 1/2017 | resTORbio | Series A | 0 |
| 6/2016 | Vedanta Biosciences | Private Equity Round | 0 |
| 1/2016 | Akili Interactive Labs | Series B | 0 |
| 12/2015 | Gelesis | Private Equity Round | 0 |
| 4/2015 | Tal Medical | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2015 | Equity | $50M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
